CN114656389B - A kind of synthetic method of 1-phenylpyrrolidine - Google Patents
A kind of synthetic method of 1-phenylpyrrolidine Download PDFInfo
- Publication number
- CN114656389B CN114656389B CN202210448626.3A CN202210448626A CN114656389B CN 114656389 B CN114656389 B CN 114656389B CN 202210448626 A CN202210448626 A CN 202210448626A CN 114656389 B CN114656389 B CN 114656389B
- Authority
- CN
- China
- Prior art keywords
- phenylpyrrolidine
- copper
- aromatic nitro
- nitro compound
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- VDQQJMHXZCMNMU-UHFFFAOYSA-N 1-phenylpyrrolidine Chemical compound C1CCCN1C1=CC=CC=C1 VDQQJMHXZCMNMU-UHFFFAOYSA-N 0.000 title claims abstract description 26
- 238000010189 synthetic method Methods 0.000 title 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims abstract description 69
- 238000006243 chemical reaction Methods 0.000 claims abstract description 46
- -1 aromatic nitro compound Chemical class 0.000 claims abstract description 23
- 238000000034 method Methods 0.000 claims abstract description 19
- FSQYJJHVABILHQ-UHFFFAOYSA-N 4-(4-methylphenyl)sulfonyloxybutyl 4-methylbenzenesulfonate Chemical compound C1=CC(C)=CC=C1S(=O)(=O)OCCCCOS(=O)(=O)C1=CC=C(C)C=C1 FSQYJJHVABILHQ-UHFFFAOYSA-N 0.000 claims abstract description 15
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000012299 nitrogen atmosphere Substances 0.000 claims abstract description 14
- 239000012074 organic phase Substances 0.000 claims abstract description 14
- 238000004440 column chromatography Methods 0.000 claims abstract description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000003054 catalyst Substances 0.000 claims abstract description 12
- 239000012153 distilled water Substances 0.000 claims abstract description 12
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims abstract description 11
- 239000003960 organic solvent Substances 0.000 claims abstract description 9
- 239000007788 liquid Substances 0.000 claims abstract description 8
- 238000001308 synthesis method Methods 0.000 claims abstract description 7
- 238000000605 extraction Methods 0.000 claims abstract description 3
- 239000012295 chemical reaction liquid Substances 0.000 claims abstract 2
- 238000001035 drying Methods 0.000 claims abstract 2
- 238000002156 mixing Methods 0.000 claims abstract 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 24
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Natural products CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 14
- 239000003208 petroleum Substances 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 11
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 10
- 239000003480 eluent Substances 0.000 claims description 10
- XTVVROIMIGLXTD-UHFFFAOYSA-N copper(II) nitrate Chemical compound [Cu+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O XTVVROIMIGLXTD-UHFFFAOYSA-N 0.000 claims description 9
- 230000002194 synthesizing effect Effects 0.000 claims description 8
- SECXISVLQFMRJM-UHFFFAOYSA-N NMP Substances CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 claims description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 6
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 claims description 6
- JJLJMEJHUUYSSY-UHFFFAOYSA-L copper(II) hydroxide Inorganic materials [OH-].[OH-].[Cu+2] JJLJMEJHUUYSSY-UHFFFAOYSA-L 0.000 claims description 6
- QTMDXZNDVAMKGV-UHFFFAOYSA-L copper(ii) bromide Chemical compound [Cu+2].[Br-].[Br-] QTMDXZNDVAMKGV-UHFFFAOYSA-L 0.000 claims description 6
- SBTSVTLGWRLWOD-UHFFFAOYSA-L copper(ii) triflate Chemical compound [Cu+2].[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F SBTSVTLGWRLWOD-UHFFFAOYSA-L 0.000 claims description 6
- 239000010949 copper Substances 0.000 claims description 5
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- 125000003118 aryl group Chemical group 0.000 claims description 4
- OPQARKPSCNTWTJ-UHFFFAOYSA-L copper(ii) acetate Chemical compound [Cu+2].CC([O-])=O.CC([O-])=O OPQARKPSCNTWTJ-UHFFFAOYSA-L 0.000 claims description 4
- 229910052736 halogen Inorganic materials 0.000 claims description 4
- 150000002367 halogens Chemical class 0.000 claims description 4
- 150000002431 hydrogen Chemical class 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 229910021590 Copper(II) bromide Inorganic materials 0.000 claims description 3
- 229910021592 Copper(II) chloride Inorganic materials 0.000 claims description 3
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 claims description 3
- 229910000366 copper(II) sulfate Inorganic materials 0.000 claims description 3
- AEJIMXVJZFYIHN-UHFFFAOYSA-N copper;dihydrate Chemical compound O.O.[Cu] AEJIMXVJZFYIHN-UHFFFAOYSA-N 0.000 claims description 3
- QYCVHILLJSYYBD-UHFFFAOYSA-L copper;oxalate Chemical compound [Cu+2].[O-]C(=O)C([O-])=O QYCVHILLJSYYBD-UHFFFAOYSA-L 0.000 claims description 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 3
- 125000003944 tolyl group Chemical group 0.000 claims 1
- 238000003786 synthesis reaction Methods 0.000 abstract description 20
- 230000015572 biosynthetic process Effects 0.000 abstract description 15
- 239000000543 intermediate Substances 0.000 abstract description 6
- 238000005516 engineering process Methods 0.000 abstract description 2
- 238000002360 preparation method Methods 0.000 abstract description 2
- 238000005580 one pot reaction Methods 0.000 abstract 1
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 18
- 239000002994 raw material Substances 0.000 description 12
- 239000002904 solvent Substances 0.000 description 11
- 239000000047 product Substances 0.000 description 10
- 239000011541 reaction mixture Substances 0.000 description 10
- 238000005481 NMR spectroscopy Methods 0.000 description 9
- 238000004009 13C{1H}-NMR spectroscopy Methods 0.000 description 8
- 239000012071 phase Substances 0.000 description 8
- SIPUZPBQZHNSDW-UHFFFAOYSA-N bis(2-methylpropyl)aluminum Chemical compound CC(C)C[Al]CC(C)C SIPUZPBQZHNSDW-UHFFFAOYSA-N 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N monobenzene Natural products C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 5
- 239000005416 organic matter Substances 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical compound OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 4
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000012263 liquid product Substances 0.000 description 3
- GETTZEONDQJALK-UHFFFAOYSA-N (trifluoromethyl)benzene Chemical compound FC(F)(F)C1=CC=CC=C1 GETTZEONDQJALK-UHFFFAOYSA-N 0.000 description 2
- JMVIVASFFKKFQK-UHFFFAOYSA-N 1-phenylpyrrolidin-2-one Chemical compound O=C1CCCN1C1=CC=CC=C1 JMVIVASFFKKFQK-UHFFFAOYSA-N 0.000 description 2
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 2
- 229910002651 NO3 Inorganic materials 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 239000012300 argon atmosphere Substances 0.000 description 2
- 150000001500 aryl chlorides Chemical class 0.000 description 2
- MCQRPQCQMGVWIQ-UHFFFAOYSA-N boron;methylsulfanylmethane Chemical compound [B].CSC MCQRPQCQMGVWIQ-UHFFFAOYSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000002532 enzyme inhibitor Substances 0.000 description 2
- 238000009776 industrial production Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000002105 nanoparticle Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- DPQIAEJLCJLSJK-UHFFFAOYSA-N 1-(4-chlorophenyl)pyrrolidine Chemical compound C1=CC(Cl)=CC=C1N1CCCC1 DPQIAEJLCJLSJK-UHFFFAOYSA-N 0.000 description 1
- IIYRJYZDFOBAKW-UHFFFAOYSA-N 1-(4-fluorophenyl)pyrrolidine Chemical compound C1=CC(F)=CC=C1N1CCCC1 IIYRJYZDFOBAKW-UHFFFAOYSA-N 0.000 description 1
- STRWKFUEXQHMFW-UHFFFAOYSA-N 1-(4-methylphenyl)pyrrolidine Chemical compound C1=CC(C)=CC=C1N1CCCC1 STRWKFUEXQHMFW-UHFFFAOYSA-N 0.000 description 1
- XAIOGMOTJLWPAJ-UHFFFAOYSA-N 1-[4-(trifluoromethyl)phenyl]pyrrolidine Chemical compound C1=CC(C(F)(F)F)=CC=C1N1CCCC1 XAIOGMOTJLWPAJ-UHFFFAOYSA-N 0.000 description 1
- WFQDTOYDVUWQMS-UHFFFAOYSA-N 1-fluoro-4-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C=C1 WFQDTOYDVUWQMS-UHFFFAOYSA-N 0.000 description 1
- CZGCEKJOLUNIFY-UHFFFAOYSA-N 4-Chloronitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(Cl)C=C1 CZGCEKJOLUNIFY-UHFFFAOYSA-N 0.000 description 1
- SZBGQDXLNMELTB-UHFFFAOYSA-N 4-fluoro-n-methyl-n-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]-2-(trifluoromethyl)benzamide Chemical compound C=1C=C(F)C=C(C(F)(F)F)C=1C(=O)N(C)C(CC1)CCN1C(C1=CC=CC=C11)=NN=C1C1=CC=NN1C SZBGQDXLNMELTB-UHFFFAOYSA-N 0.000 description 1
- ZPTVNYMJQHSSEA-UHFFFAOYSA-N 4-nitrotoluene Chemical compound CC1=CC=C([N+]([O-])=O)C=C1 ZPTVNYMJQHSSEA-UHFFFAOYSA-N 0.000 description 1
- ZNMSYUCZLWETII-UHFFFAOYSA-N 4-pyrrolidin-1-ylbenzonitrile Chemical compound C1=CC(C#N)=CC=C1N1CCCC1 ZNMSYUCZLWETII-UHFFFAOYSA-N 0.000 description 1
- AILRADAXUVEEIR-UHFFFAOYSA-N 5-chloro-4-n-(2-dimethylphosphorylphenyl)-2-n-[2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]pyrimidine-2,4-diamine Chemical compound COC1=CC(N2CCC(CC2)N2CCN(C)CC2)=CC=C1NC(N=1)=NC=C(Cl)C=1NC1=CC=CC=C1P(C)(C)=O AILRADAXUVEEIR-UHFFFAOYSA-N 0.000 description 1
- NOVKHIQVXQKSRL-UHFFFAOYSA-N 5-nitro-1-benzothiophene Chemical compound [O-][N+](=O)C1=CC=C2SC=CC2=C1 NOVKHIQVXQKSRL-UHFFFAOYSA-N 0.000 description 1
- LFAINLHFUYHZSV-UHFFFAOYSA-N 8-pyrrolidin-1-ylquinoline Chemical compound C1CCCN1C1=CC=CC2=CC=CN=C12 LFAINLHFUYHZSV-UHFFFAOYSA-N 0.000 description 1
- 102100033793 ALK tyrosine kinase receptor Human genes 0.000 description 1
- 208000031261 Acute myeloid leukaemia Diseases 0.000 description 1
- 229940122531 Anaplastic lymphoma kinase inhibitor Drugs 0.000 description 1
- 206010004146 Basal cell carcinoma Diseases 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical group [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 208000033776 Myeloid Acute Leukemia Diseases 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 238000005576 amination reaction Methods 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 150000001502 aryl halides Chemical class 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 229950004272 brigatinib Drugs 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 238000012824 chemical production Methods 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000000599 controlled substance Substances 0.000 description 1
- OXFZSJOUPRCPJO-UHFFFAOYSA-N copper ethyl 3-oxobutanoate Chemical compound [Cu+2].CCOC(=O)[CH-]C(C)=O.CCOC(=O)[CH-]C(C)=O OXFZSJOUPRCPJO-UHFFFAOYSA-N 0.000 description 1
- SFAIGHZDVQCLIO-UHFFFAOYSA-L copper;2,2,2-trifluoroacetate;hydrate Chemical compound O.[Cu+2].[O-]C(=O)C(F)(F)F.[O-]C(=O)C(F)(F)F SFAIGHZDVQCLIO-UHFFFAOYSA-L 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000006880 cross-coupling reaction Methods 0.000 description 1
- 150000004292 cyclic ethers Chemical class 0.000 description 1
- BYUYRWRYAISPPF-UHFFFAOYSA-N cyclobutyloxycyclobutane Chemical compound C1CCC1OC1CCC1 BYUYRWRYAISPPF-UHFFFAOYSA-N 0.000 description 1
- 125000004989 dicarbonyl group Chemical group 0.000 description 1
- 229960001760 dimethyl sulfoxide Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229940125532 enzyme inhibitor Drugs 0.000 description 1
- GYQYAJJFPNQOOW-UHFFFAOYSA-N gilteritinib Chemical compound N1=C(NC2CCOCC2)C(CC)=NC(C(N)=O)=C1NC(C=C1OC)=CC=C1N(CC1)CCC1N1CCN(C)CC1 GYQYAJJFPNQOOW-UHFFFAOYSA-N 0.000 description 1
- 229950006304 gilteritinib Drugs 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- WIJZXSAJMHAVGX-DHLKQENFSA-N ivosidenib Chemical compound FC1=CN=CC(N([C@H](C(=O)NC2CC(F)(F)C2)C=2C(=CC=CC=2)Cl)C(=O)[C@H]2N(C(=O)CC2)C=2N=CC=C(C=2)C#N)=C1 WIJZXSAJMHAVGX-DHLKQENFSA-N 0.000 description 1
- 229950010738 ivosidenib Drugs 0.000 description 1
- 150000002611 lead compounds Chemical class 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 208000002154 non-small cell lung carcinoma Diseases 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 150000003142 primary aromatic amines Chemical class 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 238000006268 reductive amination reaction Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 229950000062 taladegib Drugs 0.000 description 1
- 229930192474 thiophene Natural products 0.000 description 1
- 238000006257 total synthesis reaction Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- XLRPYZSEQKXZAA-OCAPTIKFSA-N tropane Chemical compound C1CC[C@H]2CC[C@@H]1N2C XLRPYZSEQKXZAA-OCAPTIKFSA-N 0.000 description 1
- 229930004006 tropane Natural products 0.000 description 1
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Catalysts (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
Description
技术领域Technical field
本发明属于有机合成中间体的制备技术领域,具体涉及一类由芳香类硝基化合物和1,4-丁二醇双(4-甲基苯磺酸酯)作为底物,制备有机中间体1-苯基吡咯烷的方法。The invention belongs to the technical field of preparation of organic synthesis intermediates, and specifically relates to a class of organic intermediates 1 prepared from aromatic nitro compounds and 1,4-butanediol bis(4-methylbenzenesulfonate) as substrates. -Phenylpyrrolidine method.
背景技术Background technique
1-苯基吡咯烷是一种重要有机合成中间体,被广泛应用于科学研究、药物合成、生物碱合成、化工生产等多个领域。在天然生物碱、托烷类药物分子、新药先导化合物中广泛存在。同时这类化合物也是药物合成中常用的合成砌块,常被应用于一些其他具有广泛生物活性的天然产物的全合成研究。因此,类似1-苯基吡咯烷的N-芳基取代氮杂环在有机合成和药学研究中具有很高的应用价值。1-Phenylpyrrolidine is an important organic synthesis intermediate and is widely used in scientific research, drug synthesis, alkaloid synthesis, chemical production and other fields. It is widely found in natural alkaloids, tropane drug molecules, and new drug lead compounds. At the same time, this type of compound is also a commonly used synthetic building block in drug synthesis, and is often used in the total synthesis research of some other natural products with a wide range of biological activities. Therefore, N-aryl-substituted nitrogen heterocycles similar to 1-phenylpyrrolidine have high application value in organic synthesis and pharmaceutical research.
目前1-苯基吡咯烷及其衍生物被发现具有广泛的生理活性,可以作为生物酶抑制剂或具有抗癌作用。一些在药学研究中被发现的受到广泛关注的相关化合物举例如下:被批准用于治疗局部晚期基底细胞癌的Taladegib(A);第一个在人体试验中获得临床验证mIDH1酶抑制剂Ivosidenib(B);新一代间变性淋巴瘤激酶抑制剂Brigatinib(C)对ALK阳性的非小细胞肺癌患者有很强的疗效。此外,Gilteritinib(D)可以提高一些急性髓系白血病患者的存活率。At present, 1-phenylpyrrolidine and its derivatives have been found to have a wide range of physiological activities and can be used as biological enzyme inhibitors or have anti-cancer effects. Some examples of related compounds discovered in pharmaceutical research that have received widespread attention are as follows: Taladegib (A), which was approved for the treatment of locally advanced basal cell carcinoma; Ivosidenib (B), the first mIDH1 enzyme inhibitor to be clinically validated in human trials ); the new generation anaplastic lymphoma kinase inhibitor Brigatinib (C) has strong efficacy in patients with ALK-positive non-small cell lung cancer. In addition, Gilteritinib(D) may improve survival in some patients with acute myeloid leukemia.
目前,1-苯基吡咯烷可以通过以下方法进行合成。Currently, 1-phenylpyrrolidine can be synthesized by the following methods.
1)苯基-2-吡咯烷酮与二异丁基硼氢化铝的还原反应:首先需要由二异丁基氢化铝(DIBAL)和硼烷二甲硫醚(BMS)合成二异丁基硼氢化铝,将1-苯基-2-吡咯烷酮(1当量)、二异丁基硼氢化铝(1.1当量)与无水THF在0℃混合。一旦添加了所有的氢化物,就移除冰浴并且在氩气氛围下将反应混合物继续搅拌1小时再经过后处理即可得到产品。该方法所用二异丁基硼氢化铝(iBu)2AlBH4无法直接购买,需要复杂的合成步骤,且反应需要在0℃和氩气氛围下进行,反应条件苛刻。参考:Gabriella Amberchan,Rachel A.Snelling,EnriqueMoya,J.Org.Chem.2021,86,6207.。1) Reduction reaction of phenyl-2-pyrrolidone and diisobutylaluminum borohydride: First, diisobutylaluminum borohydride needs to be synthesized from diisobutylaluminum hydride (DIBAL) and borane dimethyl sulfide (BMS) , 1-phenyl-2-pyrrolidone (1 equivalent), diisobutylaluminum borohydride (1.1 equivalent) and anhydrous THF were mixed at 0°C. Once all hydrides have been added, the ice bath is removed and the reaction mixture is stirred under an argon atmosphere for an additional hour before work-up to obtain the product. The diisobutylaluminum borohydride (iBu) 2 AlBH 4 used in this method cannot be purchased directly, requires complicated synthesis steps, and the reaction needs to be carried out at 0°C and an argon atmosphere, and the reaction conditions are harsh. Reference: Gabriella Amberchan, Rachel A. Snelling, Enrique Moya, J. Org. Chem. 2021, 86, 6207.
2)苯胺与环醚的脱氧胺化反应:该反应首先需要将苯胺、环丁醚,I2、NaH2PO2添加到密闭的反应管当中,在160℃的温度下反应11h,分离即可得到1-苯基吡咯烷,该反应160℃的反应温度要求非常苛刻,温度略微降低产率就会出现极大的下降,而且副产物有HI,具有强腐蚀性,处理过程复杂。参考:Ying Lin,Dongyang Li,Jingjing Zhang,Zhi Tang,NewJ.Chem.,2021,45,21011.。2) Deoxyamination reaction of aniline and cyclic ether: This reaction first requires adding aniline, cyclobutyl ether, I 2 , and NaH 2 PO 2 into a closed reaction tube, reacting at 160°C for 11 hours, and then separating. To obtain 1-phenylpyrrolidine, the reaction temperature of 160°C is very demanding. If the temperature is slightly lowered, the yield will drop greatly. Moreover, the by-product contains HI, which is highly corrosive and the treatment process is complicated. Reference: Ying Lin, Dongyang Li, Jingjing Zhang, Zhi Tang, NewJ.Chem., 2021, 45, 21011..
3)苯硼酸与N-杂环化合物的C-N交叉偶联反应:该反应采用一种新型的纳米粒子作为催化剂,将苯硼酸、N-杂环化合物、K3PO4、蒸馏水和催化剂在60℃下反应一段时间即可得到目标产物,但该反应所需的纳米粒子合成复杂,而且催化剂中所用到的金属钴具有很强的毒性,操作过程复杂。参考:Seyyedeh Ameneh Alavi G,Mohammad Ali Nasseri,MiladKazemnejadi,New J.Chem.,2021,45,7741.。3) CN cross-coupling reaction of phenylboronic acid and N-heterocyclic compounds: This reaction uses a new type of nanoparticles as a catalyst, and combines phenylboronic acid, N-heterocyclic compounds, K 3 PO 4 , distilled water and catalyst at 60°C The target product can be obtained by reacting for a period of time, but the synthesis of nanoparticles required for this reaction is complicated, and the metal cobalt used in the catalyst is highly toxic, making the operation process complicated. Reference: Seyyedeh Ameneh Alavi G, Mohammad Ali Nasseri, Milad Kazemnejadi, New J. Chem., 2021, 45, 7741..
4)镍催化的芳基氯化物与酰胺的偶联胺化反应:该反应需要保持在35℃的氮气气氛下,在反应管中加入溶剂甲苯、芳基氯、酰胺、Ni(COD)2、Apr·HCl、KOtBu和H2O反应24h。该反应的需要时刻保持在氮气氛围下,且所用溶剂甲苯是管制药品,条件要求苛刻。参考:Jinpeng Li,Changyu Huang,Daheng Wen,Qingshu Zheng,Org.Lett.2021,23,687.。4) Nickel-catalyzed coupling amination reaction of aryl chlorides and amides: This reaction needs to be maintained under a nitrogen atmosphere at 35°C, and the solvent toluene, aryl chloride, amide, Ni(COD) 2 , and Apr·HCl, KO t Bu and H 2 O reacted for 24h. This reaction needs to be kept under a nitrogen atmosphere at all times, and the solvent toluene used is a controlled drug, so the conditions are harsh. Reference: Jinpeng Li, Changyu Huang, Daheng Wen, Qingshu Zheng, Org. Lett. 2021, 23, 687..
5)芳基卤化物的加氢脱卤化反应:该反应在氮气气氛下进行,向压力管中加入2-碘-1-苯基-吡咯烷、催化剂、微量钾、KOtBu,溶剂为二甲基亚砜和二恶烷按照一定比例配制而成,反应24h。该反应需要氮气保护且用到压力管,原料中用到了活泼的钾金属,反应的危险性较大,所用底物需要自己合成,不易获得,并且反应不易操作。参考:Bhagat Singh,Jasimuddin Ahmed,Amit Biswas,Rupankar Paira,J.Org.Chem.2021,86,7242.。5) Hydrodehalogenation reaction of aryl halides: This reaction is carried out under a nitrogen atmosphere. Add 2-iodo-1-phenyl-pyrrolidine, catalyst, trace potassium, KO t Bu to the pressure tube, and the solvent is dihydrogen. Methyl sulfoxide and dioxane were prepared according to a certain ratio and reacted for 24 hours. This reaction requires nitrogen protection and a pressure tube. Active potassium metal is used in the raw materials. The reaction is very dangerous. The substrate needs to be synthesized by yourself, which is not easy to obtain, and the reaction is not easy to operate. Reference: Bhagat Singh, Jasimuddin Ahmed, Amit Biswas, Rupankar Paira, J.Org.Chem.2021,86,7242..
综上所述,尽管1-苯基吡咯烷是一种重要的有机合成中间体,但是到目前为止,现有的合成方法都是伯芳胺作为原料的反应或使用二羰基化合物进行还原胺化,但这些方法底物的功能耐受性存在局限性,而且条件要求高,操作复杂,不利于工业化生产。因此,开发一种新的合成方法,有着十分重要意义。In summary, although 1-phenylpyrrolidine is an important organic synthesis intermediate, so far, the existing synthesis methods are the reaction of primary aromatic amines as raw materials or the use of dicarbonyl compounds for reductive amination. , but these methods have limitations in the functional tolerance of the substrates, high requirements for conditions, and complex operations, which are not conducive to industrial production. Therefore, it is of great significance to develop a new synthesis method.
发明内容Contents of the invention
本发明的目的是提供一种1-苯基吡咯烷的合成方法,该方法简单、成本低、产率高且能够一步反应合成1-苯基吡咯烷,该方法拓宽了现有合成技术。The object of the present invention is to provide a synthesis method of 1-phenylpyrrolidine, which is simple, low-cost, high-yield and capable of synthesizing 1-phenylpyrrolidine in one step. This method broadens the existing synthesis technology.
为实现上述目的,本发明采用的技术方案为:In order to achieve the above objects, the technical solutions adopted by the present invention are:
一种1-苯基吡咯烷的合成方法,具体为:在氮气氛围下,向干燥的schlenk反应管中依次加入催化剂Cu(II),锌粉,以及有机溶剂,随后加入芳香类硝基化合物和1,4-丁二醇双(4-甲基苯磺酸酯),在50~80℃下反应8h,待芳香类硝基化合物完全转化后,向反应液中加入蒸馏水和乙酸乙酯的混合液萃取,合并有机相并加入无水硫酸镁进行干燥,40℃下浓缩有机相,经柱层析得到目标产物1-苯基吡咯烷。A method for synthesizing 1-phenylpyrrolidine, specifically: in a nitrogen atmosphere, sequentially add catalyst Cu(II), zinc powder, and organic solvent to a dry schlenk reaction tube, and then add aromatic nitro compounds and 1,4-Butanediol bis(4-methylbenzenesulfonate), react at 50-80°C for 8 hours. After the aromatic nitro compounds are completely converted, add a mixture of distilled water and ethyl acetate to the reaction solution. Liquid extraction, combine the organic phases and add anhydrous magnesium sulfate to dry, concentrate the organic phase at 40°C, and obtain the target product 1-phenylpyrrolidine through column chromatography.
进一步,所述芳香类硝基化合物为硝基苯或杂芳基苯。Further, the aromatic nitro compound is nitrobenzene or heteroarylbenzene.
进一步,所述硝基苯的结构式为所述杂芳基苯结构式为/>其中R1为氢、卤素、烷基、芳基、-OMe、-CHO、-CN、-SCH3中的任意一种或两种,但不仅限于这些基团。Further, the structural formula of nitrobenzene is The structural formula of the heteroaryl benzene is/> Wherein R 1 is any one or two of hydrogen, halogen, alkyl, aryl, -OMe, -CHO, -CN, -SCH 3 , but is not limited to these groups.
进一步,所述1,4-丁二醇双(4-甲基苯磺酸酯)与芳香类硝基化合物的摩尔比为2-3:1。Further, the molar ratio of the 1,4-butanediol bis(4-methylbenzenesulfonate) to the aromatic nitro compound is 2-3:1.
进一步,所述催化剂Cu(II)为硫酸铜(II)、草酸铜(II)、氯化铜(II)、硝酸铜(II)、溴化铜(II)、三氟甲磺酸铜(II)、氢氧化铜(II)、乙基乙酰乙酸铜(II)、三氟乙酸铜(II)水合物中的一种,但不仅限于上述催化剂Cu(II)。Further, the catalyst Cu (II) is copper (II) sulfate, copper (II) oxalate, copper (II) chloride, copper (II) nitrate, copper (II) bromide, and copper (II) triflate. ), copper (II) hydroxide, copper (II) ethyl acetoacetate, copper (II) trifluoroacetate hydrate, but is not limited to the above catalyst Cu (II).
进一步,所述催化剂Cu(II)的用量为芳香类硝基化合物的3~5mol%。Further, the usage amount of the catalyst Cu(II) is 3 to 5 mol% of the aromatic nitro compound.
进一步,所述有机溶剂为Toluene、1,4-Dioxane、THF、DMSO、CH3CN、NMP、DMF中的一种,但不仅限于上述有机溶剂。Further, the organic solvent is one of Toluene, 1,4-Dioxane, THF, DMSO, CH 3 CN, NMP, and DMF, but is not limited to the above organic solvent.
进一步,所述有机溶剂用量为每毫摩尔芳香类硝基化合物对应1mL~4mL的有机溶剂。Further, the amount of organic solvent used is 1 mL to 4 mL of organic solvent per millimole of the aromatic nitro compound.
进一步,所述锌粉与芳香类硝基化合物的摩尔比为1.5:1,锌粉用于还原硝基苯或杂芳基苯。Further, the molar ratio of the zinc powder to the aromatic nitro compound is 1.5:1, and the zinc powder is used to reduce nitrobenzene or heteroaryl benzene.
进一步,所述柱层析的洗脱剂为乙酸乙酯和石油醚的混合物,乙酸乙酯与石油醚的体积比为50:1。Further, the eluent of the column chromatography is a mixture of ethyl acetate and petroleum ether, and the volume ratio of ethyl acetate to petroleum ether is 50:1.
当反应底物之一为硝基苯时,本发明反应方程式如下:When one of the reaction substrates is nitrobenzene, the reaction equation of the present invention is as follows:
其中,R1可以为氢、卤素、烷基或者芳基等取代基团,但不仅限于这些基团。本发明所用的各种取代基的硝基苯均可商业所得;X为3~5,Y为1.5,T为50~80,式A为目标产物1-苯基吡咯烷。Among them, R 1 can be a substituent group such as hydrogen, halogen, alkyl or aryl, but is not limited to these groups. Nitrobenzene with various substituents used in the present invention can be obtained commercially; X is 3 to 5, Y is 1.5, T is 50 to 80, and formula A is the target product 1-phenylpyrrolidine.
当反应底物之一为杂芳基苯时,本发明的反应方程式与上述反应方程式类似,将上述反应方程式中的硝基苯的苯环替换为氮杂环即可。When one of the reaction substrates is heteroaryl benzene When , the reaction equation of the present invention is similar to the above reaction equation, and the benzene ring of nitrobenzene in the above reaction equation can be replaced by a nitrogen heterocyclic ring.
与现有技术相比,本发明的有益效果为:Compared with the prior art, the beneficial effects of the present invention are:
1、本发明方法中原料廉价易得,符合工业化生产的要求。1. The raw materials in the method of the present invention are cheap and easy to obtain, and meet the requirements of industrial production.
2、本发明方法中反应无复杂的中间环节,对实验操作水平要求较低。2. There are no complex intermediate links in the reaction in the method of the present invention, and the requirements for experimental operation level are low.
3、本发明方法从硝基苯为原料,合成目标产物,拓宽了1-苯基-吡咯烷的合成方法。3. The method of the present invention uses nitrobenzene as raw material to synthesize the target product, which broadens the synthesis method of 1-phenyl-pyrrolidine.
具体实施方式Detailed ways
下面结合具体的实施例对本发明的技术方案及效果做进一步描述,但本发明的保护范围并不限于此。The technical solutions and effects of the present invention will be further described below with reference to specific examples, but the scope of the present invention is not limited thereto.
以下实施例的反应方程式中,I表示硝基苯或杂芳基苯,II表示1,4-丁二醇双(4-甲基苯磺酸酯)。In the reaction equations of the following examples, I represents nitrobenzene or heteroarylbenzene, and II represents 1,4-butanediol bis(4-methylbenzenesulfonate).
实施例1Example 1
本实施例1-苯基吡咯烷1的合成为:The synthesis of Example 1-phenylpyrrolidine 1 is:
在氮气氛围下,向干燥的25mL schlenk反应管中依次加入氯化铜(Ⅱ)[2mg,0.015mmol],锌粉(49mg,0.75mmol),溶剂DMF(2mL),硝基苯(51μL,0.5mmol),1,4-丁二醇双(4-甲基苯磺酸酯)(321μL,1mmol)。在转速为360rpm,65℃的加热器上反应8h,经TLC检测原料反应完全,停止反应,将反应混合液用体积比为1:2的蒸馏水和乙酸乙酯混合液少量多次萃取,合并有机相,并用无水硫酸镁进行干燥,浓缩有机相,经柱层析分离,洗脱剂为(乙酸乙酯/石油醚=50/1),得到产品浅黄色液体67mg,产率94%。Under a nitrogen atmosphere, add copper (II) chloride [2 mg, 0.015 mmol], zinc powder (49 mg, 0.75 mmol), solvent DMF (2 mL), and nitrobenzene (51 μL, 0.5 mmol), 1,4-butanediol bis(4-methylbenzenesulfonate) (321 μL, 1 mmol). React for 8 hours on a heater with a rotating speed of 360 rpm and 65°C. TLC detects that the raw material reaction is complete. Stop the reaction. Extract the reaction mixture with a mixture of distilled water and ethyl acetate with a volume ratio of 1:2. Extract the reaction mixture several times, and combine the organic matter. phase and dried over anhydrous magnesium sulfate. The organic phase was concentrated and separated by column chromatography. The eluent was (ethyl acetate/petroleum ether = 50/1) to obtain 67 mg of the product as a light yellow liquid with a yield of 94%.
1H NMR(400MHz,CDCl3)δ7.17–7.13(m,2H),6.59–6.56(t,1H),6.50–6.48(d,2H),3.22–3.18(m,4H),1.93–1.90(m,4H).13C{1H}NMR(100MHz,CDCl3)δ147.5,128.3,114.5,110.3,46.1,24.2.Ms(EI):m/z=147.5[M]+. 1 H NMR (400MHz, CDCl 3 ) δ7.17–7.13(m,2H),6.59–6.56(t,1H),6.50–6.48(d,2H),3.22–3.18(m,4H),1.93–1.90 (m,4H). 13 C{1H}NMR (100MHz, CDCl 3 ) δ147.5,128.3,114.5,110.3,46.1,24.2.Ms(EI): m/z=147.5[M]+.
实施例2Example 2
本实施例1-(对甲苯基)吡咯烷2的合成为:The synthesis of Example 1-(p-tolyl)pyrrolidine 2 is:
在氮气氛围下,向干燥的25mL schlenk反应瓶中依次加入硫酸铜(II)[4mg,0.025mmol],锌粉(49mg,0.75mmol),溶剂Toluene(0.5mL),对硝基甲苯(69mg,0.5mmol),1,4-丁二醇双(4-甲基苯磺酸酯)(468μL,1.5mmol)。在转速为200rpm,50℃的加热器上反应8h,经TLC检测原料反应完全,停止反应,将反应混合液用体积比为1:2的蒸馏水和乙酸乙酯混合液少量多次萃取,合并有机相,并用无水硫酸镁进行干燥,浓缩有机相,后经柱层析,洗脱剂为(乙酸乙酯/石油醚=50/1),得到产品浅黄色液体76mg,产率94%。Under a nitrogen atmosphere, add copper (II) sulfate [4 mg, 0.025 mmol], zinc powder (49 mg, 0.75 mmol), solvent Toluene (0.5 mL), and p-nitrotoluene (69 mg, 0.5mmol), 1,4-butanediol bis(4-methylbenzenesulfonate) (468μL, 1.5mmol). React for 8 hours on a heater with a rotating speed of 200 rpm and 50°C. After TLC detects that the raw material reaction is complete, the reaction is stopped. The reaction mixture is extracted several times with a mixture of distilled water and ethyl acetate with a volume ratio of 1:2, and the organic matter is combined. phase, dried over anhydrous magnesium sulfate, concentrated the organic phase, and then subjected to column chromatography. The eluent was (ethyl acetate/petroleum ether = 50/1) to obtain 76 mg of product as a light yellow liquid with a yield of 94%.
1H NMR(400MHz,CDCl3)δ7.01(d,2H),6.54(d,2H),3.25(t,4H),2.27(s,3H),2.05–1.94(m,4H).13C{1H}NMR(100MHz,CDCl3)δ146.7,129.5,124.3,111.6,47.5,25.3,20.5.Ms(EI):m/z=161.5[M]+. 1 H NMR (400MHz, CDCl 3 ) δ7.01(d,2H),6.54(d,2H),3.25(t,4H),2.27(s,3H),2.05–1.94(m,4H). 13 C {1H}NMR (100MHz, CDCl 3 ) δ146.7,129.5,124.3,111.6,47.5,25.3,20.5.Ms(EI): m/z=161.5[M]+.
实施例3Example 3
本实施例1-(4-氟苯基)吡咯烷3的合成为:The synthesis of 1-(4-fluorophenyl)pyrrolidine 3 in this example is:
在氮气氛围下,向干燥的25mL schlenk反应瓶中依次加入草酸铜(II)[3.8mg,0.025mmol],锌粉(49mg,0.75mmol),溶剂NMP(2mL),4-氟硝基苯(70.5mg,0.5mmol),1,4-丁二醇双(4-甲基苯磺酸酯)(468μL,1.5mmol)。在转速为150rpm,80℃的加热器上反应8h,经TLC检测原料反应完全,停止反应,将反应混合液用体积比为1:2的蒸馏水和乙酸乙酯混合液少量多次萃取,合并有机相,并用无水硫酸镁进行干燥,浓缩有机相,后经柱层析,洗脱剂为(乙酸乙酯/石油醚=50/1),得到产品浅黄色液体77.6mg,产率94%。Under a nitrogen atmosphere, add copper (II) oxalate [3.8 mg, 0.025 mmol], zinc powder (49 mg, 0.75 mmol), solvent NMP (2 mL), and 4-fluoronitrobenzene ( 70.5 mg, 0.5 mmol), 1,4-butanediol bis(4-methylbenzenesulfonate) (468 μL, 1.5 mmol). React for 8 hours on a heater with a rotating speed of 150 rpm and 80°C. After TLC tests, the raw materials are completely reacted and the reaction is stopped. The reaction mixture is extracted several times with a mixture of distilled water and ethyl acetate with a volume ratio of 1:2, and the organic matter is combined. phase, dried over anhydrous magnesium sulfate, concentrated the organic phase, and then subjected to column chromatography. The eluent was (ethyl acetate/petroleum ether = 50/1) to obtain 77.6 mg of product as a light yellow liquid with a yield of 94%.
1HNMR(400MHz,CDCl3)δ7.01–6.84(m,2H),6.57–6.48(m,2H),3.23(t,4H),2.03–1.95(m,4H).13C{1H}NMR(100MHz,CDCl3)δ155.1,144.5,115.4,112.1,48.7,25.6.19F NMR(376MHz,CDCl3)δ-130.93.Ms(EI):m/z=165.5[M]+. 1 HNMR (400MHz, CDCl 3 ) δ7.01–6.84(m,2H),6.57–6.48(m,2H),3.23(t,4H),2.03–1.95(m,4H). 13 C{1H}NMR (100MHz, CDCl 3 ) δ 155.1, 144.5, 115.4, 112.1, 48.7, 25.6. 19 F NMR (376MHz, CDCl 3 ) δ-130.93. Ms (EI): m/z=165.5[M]+.
实施例4Example 4
本实施例1-(4-氯苯基)吡咯烷4的合成为:The synthesis of 1-(4-chlorophenyl)pyrrolidine 4 in this example is:
在氮气氛围下,向干燥的25mL schlenk反应瓶中依次加入硝酸铜(II)[2.80mg,0.015mmol],锌粉(49mg,0.75mmol),溶剂DMSO(2mL),4-氯硝基苯(79mg,0.5mmol),1,4-丁二醇双(4-甲基苯磺酸酯)(312μL,1mmol)。在转速为150rpm,70℃的加热器上反应8h,经TLC检测原料反应完全,停止反应,将反应混合液用体积比为1:2的蒸馏水和乙酸乙酯混合液少量多次萃取,合并有机相,并用无水硫酸镁进行干燥,浓缩有机相,后经柱层析,洗脱剂为(乙酸乙酯/石油醚=50/1),得到产品浅黄色液体87mg,产率96%。Under a nitrogen atmosphere, add copper (II) nitrate [2.80 mg, 0.015 mmol], zinc powder (49 mg, 0.75 mmol), solvent DMSO (2 mL), and 4-chloronitrobenzene ( 79 mg, 0.5 mmol), 1,4-butanediol bis(4-methylbenzenesulfonate) (312 μL, 1 mmol). React for 8 hours on a heater with a rotating speed of 150 rpm and 70°C. TLC detects that the raw material reaction is complete. Stop the reaction. Extract the reaction mixture with a mixture of distilled water and ethyl acetate with a volume ratio of 1:2. phase, dried over anhydrous magnesium sulfate, concentrated the organic phase, and then subjected to column chromatography. The eluent was (ethyl acetate/petroleum ether = 50/1) to obtain 87 mg of a light yellow liquid product with a yield of 96%.
1H NMR(400MHz,CDCl3)δ7.24–7.11(m,2H),6.54–6.42(m,2H),3.24(t,4H),2.01–1.95(m,4H).13C{1H}NMR(100MHz,CDCl3)δ146.5,128.2,120.8,112.3,47.4,25.4.Ms(EI):m/z=181.3[M]+. 1 H NMR (400MHz, CDCl 3 ) δ7.24–7.11(m,2H),6.54–6.42(m,2H),3.24(t,4H),2.01–1.95(m,4H). 13 C{1H} NMR (100MHz, CDCl 3 ) δ 146.5, 128.2, 120.8, 112.3, 47.4, 25.4.Ms (EI): m/z=181.3[M]+.
实施例5Example 5
本实施例4-(吡咯烷-1-基)苄腈5的合成为:The synthesis of 4-(pyrrolidin-1-yl)benzonitrile 5 in this example is:
在氮气氛围下,向干燥的25mL schlenk反应瓶中依次加入氢氧化铜(II)[1.46mg,0.015mmol],锌粉(49mg,0.75mmol),溶剂1,4-Dioxane(1mL),对硝基苯甲腈(74mg,0.5mmol),1,4-丁二醇双(4-甲基苯磺酸酯)(312μL,1mmol)。在转速为150rpm,70℃的加热器上反应8h,经TLC检测原料反应完全,停止反应,将反应混合液用体积比为1:2的蒸馏水和乙酸乙酯混合液少量多次萃取,合并有机相,并用无水硫酸镁进行干燥,浓缩有机相,后经柱层析,洗脱剂为(乙酸乙酯/石油醚=50/1),得到产品浅黄色液体82mg,产率95%。Under a nitrogen atmosphere, add copper (II) hydroxide [1.46 mg, 0.015 mmol], zinc powder (49 mg, 0.75 mmol), solvent 1,4-Dioxane (1 mL), and p-nitrogen in order to a dry 25 mL schlenk reaction flask. 1,4-butanediol bis(4-methylbenzenesulfonate) (312 μL, 1 mmol). React for 8 hours on a heater with a rotating speed of 150 rpm and 70°C. TLC detects that the raw material reaction is complete. Stop the reaction. Extract the reaction mixture with a mixture of distilled water and ethyl acetate with a volume ratio of 1:2. phase, dried over anhydrous magnesium sulfate, concentrated the organic phase, and then subjected to column chromatography. The eluent was (ethyl acetate/petroleum ether = 50/1) to obtain 82 mg of a light yellow liquid product with a yield of 95%.
1H NMR(400MHz,CDCl3)δ7.46–7.41(m,2H),6.53(d,2H),3.34–3.21(m,4H),2.13–1.96(m,4H).13C{1H}NMR(100MHz,CDCl3)δ150.3,133.4,121.5,111.3,96.3,47.7,25.5.Ms(EI):m/z=172.6[M]+. 1 H NMR (400MHz, CDCl 3 ) δ7.46–7.41(m,2H),6.53(d,2H),3.34–3.21(m,4H),2.13–1.96(m,4H). 13 C{1H} NMR (100MHz, CDCl 3 ) δ 150.3, 133.4, 121.5, 111.3, 96.3, 47.7, 25.5. Ms (EI): m/z=172.6[M]+.
实施例6Example 6
本实施例1-(4-(三氟甲基)苯基)吡咯烷6的合成为:The synthesis of 1-(4-(trifluoromethyl)phenyl)pyrrolidine 6 in this example is:
在氮气氛围下,向干燥的25mL schlenk反应瓶中依次加入无水醋酸铜(II)[2.72mg,0.015mmol],锌粉(49mg,0.75mmol),溶剂CH3CN(2mL),4-硝基三氟甲苯(95.6mg,0.5mmol),1,4-丁二醇双(4-甲基苯磺酸酯)(468μL,1.5mmol)。在转速为200rpm,70℃的加热器上反应8h,经TLC检测原料反应完全,停止反应,将反应混合液用体积比为1:2的蒸馏水和乙酸乙酯混合液少量多次萃取,合并有机相,并用无水硫酸镁进行干燥,浓缩有机相,后经柱层析,洗脱剂为(乙酸乙酯/石油醚=50/1),得到产品浅黄色液体104mg,产率97%。Under a nitrogen atmosphere, add anhydrous copper (II) acetate (2.72 mg, 0.015 mmol), zinc powder (49 mg, 0.75 mmol), solvent CH 3 CN (2 mL), and 4-nitrate in order to a dry 25 mL schlenk reaction flask. Trifluorotoluene (95.6 mg, 0.5 mmol), 1,4-butanediol bis(4-methylbenzenesulfonate) (468 μL, 1.5 mmol). React for 8 hours on a heater with a rotating speed of 200 rpm and 70°C. TLC detects that the raw material reaction is complete. Stop the reaction. Extract the reaction mixture with a mixture of distilled water and ethyl acetate with a volume ratio of 1:2. phase, dried over anhydrous magnesium sulfate, concentrated the organic phase, and then subjected to column chromatography. The eluent was (ethyl acetate/petroleum ether = 50/1) to obtain 104 mg of a light yellow liquid product with a yield of 97%.
1H NMR(400MHz,CDCl3)δ7.43(d,2H),6.54(d,2H),3.33(t,4H),2.02(td,4H).13C{1H}NMR(100MHz,CDCl3)δ148.4,125.5(q,),124.2,115.3,109.5,46.3,24.7.19F NMR(376MHz,CDCl3)δ-60.55.Ms(EI):m/z=215.3[M]+. 1 H NMR (400MHz, CDCl 3 ) δ7.43 (d, 2H), 6.54 (d, 2H), 3.33 (t, 4H), 2.02 (td, 4H). 13 C{1H} NMR (100MHz, CDCl 3 )δ148.4,125.5(q,),124.2,115.3,109.5,46.3,24.7. 19 F NMR (376MHz, CDCl 3 )δ-60.55.Ms(EI): m/z=215.3[M]+.
实施例7Example 7
本实施例8-(1-吡咯烷基)-喹啉7的合成为:The synthesis of 8-(1-pyrrolidinyl)-quinoline 7 in this example is:
在氮气氛围下,向干燥的25mL schlenk反应瓶中依次加入三氟甲磺酸铜(II)[5.42mg,0.015mmol],锌粉(49mg,0.75mmol),溶剂THF(2mL),7-硝基喹啉(87mg,0.5mmol),1,4-丁二醇双(4-甲基苯磺酸酯)(468μL,1.5mmol)。在转速为200rpm,80℃的加热器上反应8h,经TLC检测原料反应完全,停止反应,将反应混合液用体积比为1:2的蒸馏水和乙酸乙酯混合液少量多次萃取,合并有机相,并用无水硫酸镁进行干燥,浓缩有机相,后经柱层析,洗脱剂为(乙酸乙酯/石油醚=50/1),得到产品浅黄色液体92mg,产率93%。Under a nitrogen atmosphere, add copper (II) triflate (II) [5.42 mg, 0.015 mmol], zinc powder (49 mg, 0.75 mmol), solvent THF (2 mL), and 7-nitrate in order to a dry 25 mL schlenk reaction bottle. Quinoline (87 mg, 0.5 mmol), 1,4-butanediol bis(4-methylbenzenesulfonate) (468 μL, 1.5 mmol). React for 8 hours on a heater with a rotating speed of 200 rpm and 80°C. After TLC detects that the raw material reaction is complete, the reaction is stopped. The reaction mixture is extracted several times with a mixture of distilled water and ethyl acetate with a volume ratio of 1:2, and the organic matter is combined. phase, dried over anhydrous magnesium sulfate, concentrated the organic phase, and then subjected to column chromatography. The eluent was (ethyl acetate/petroleum ether = 50/1) to obtain 92 mg of product as a light yellow liquid with a yield of 93%.
1H NMR(400MHz,CDCl3)δ8.77–8.74(m,1H),8.05–8.01(m,1H),7.42–7.25(m,2H),7.18–7.14(m,1H),6.84–6.81(m,1H),3.74–3.72(m,4H),2.06–1.92(m,4H).13C{1H}NMR(100MHz,CDCl3)δ146.5,141.3,135.4,129.5,127.1,120.5,116.5,111.2,52.3,25.3.Ms(EI):m/z=198.3[M]+. 1 H NMR (400MHz, CDCl 3 ) δ8.77–8.74(m,1H),8.05–8.01(m,1H),7.42–7.25(m,2H),7.18–7.14(m,1H),6.84–6.81 (m,1H),3.74–3.72(m,4H),2.06–1.92(m,4H). 13 C{1H}NMR(100MHz,CDCl 3 )δ146.5,141.3,135.4,129.5,127.1,120.5,116.5, 111.2,52.3,25.3.Ms(EI):m/z=198.3[M]+.
实施例8Example 8
本实施例5-吡咯苯并[b]噻吩8的合成为:The synthesis of Example 5-pyrrolebenzo[b]thiophene 8 is as follows:
在氮气氛围下,向干燥的25mL schlenk反应瓶中依次加入溴化铜(II)[3.35mg,0.015mmol],锌粉(49mg,0.75mmol),溶剂N-甲基吡咯烷酮(2mL),5-硝基苯并噻吩(89.6mg,0.5mmol),1,4-丁二醇双(4-甲基苯磺酸酯)(468μL,1.5mmol)。在转速为200rpm,80℃的加热器上反应8h,经TLC检测原料反应完全,停止反应,将反应混合液用体积比为1:2的蒸馏水和乙酸乙酯混合液少量多次萃取,合并有机相,并用无水硫酸镁进行干燥,浓缩有机相,后经柱层析,洗脱剂为(乙酸乙酯/石油醚=50/1),得到产品浅黄色液体116mg,产率96%。Under a nitrogen atmosphere, add copper (II) bromide [3.35 mg, 0.015 mmol], zinc powder (49 mg, 0.75 mmol), solvent N-methylpyrrolidone (2 mL), and 5- Nitrobenzothiophene (89.6 mg, 0.5 mmol), 1,4-butanediol bis(4-methylbenzenesulfonate) (468 μL, 1.5 mmol). React for 8 hours on a heater with a rotating speed of 200 rpm and 80°C. After TLC detects that the raw material reaction is complete, the reaction is stopped. The reaction mixture is extracted several times with a mixture of distilled water and ethyl acetate with a volume ratio of 1:2, and the organic matter is combined. phase, dried over anhydrous magnesium sulfate, concentrated the organic phase, and then subjected to column chromatography. The eluent was (ethyl acetate/petroleum ether = 50/1) to obtain 116 mg of product as a light yellow liquid with a yield of 96%.
1H NMR(400MHz,CDCl3)δ7.65(d,1H),7.33(d,1H),7.14(d,1H),6.94(d,1H),6.78–6.73(m,1H),3.38–3.23(m,4H),2.08–1.92(m,4H).13C{1H}NMR(100MHz,CDCl3)δ146.1,141.3,127.5,126.4,123.7,112.9,112.3,104.5,48.3,25.7.Ms(EI):m/z=203.3[M]+. 1 H NMR (400MHz, CDCl 3 ) δ7.65(d,1H),7.33(d,1H),7.14(d,1H),6.94(d,1H),6.78–6.73(m,1H),3.38– 3.23(m,4H),2.08–1.92(m,4H). 13 C{1H}NMR(100MHz, CDCl 3 )δ146.1,141.3,127.5,126.4,123.7,112.9,112.3,104.5,48.3,25.7.Ms( EI):m/z=203.3[M]+.
尽管已经示出和描述了本发明的实施例,对于本领域的普通技术人员而言,可以理解在不脱离本发明的原理和精神的情况下可以对这些实施例进行多种变化、修改、替换和变型,本发明的范围由所附权利要求及其等同物限定。Although the embodiments of the present invention have been shown and described, those of ordinary skill in the art will understand that various changes, modifications, and substitutions can be made to these embodiments without departing from the principles and spirit of the invention. and modifications, the scope of the invention is defined by the appended claims and their equivalents.
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210448626.3A CN114656389B (en) | 2022-04-27 | 2022-04-27 | A kind of synthetic method of 1-phenylpyrrolidine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210448626.3A CN114656389B (en) | 2022-04-27 | 2022-04-27 | A kind of synthetic method of 1-phenylpyrrolidine |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114656389A CN114656389A (en) | 2022-06-24 |
CN114656389B true CN114656389B (en) | 2023-12-15 |
Family
ID=82037482
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210448626.3A Active CN114656389B (en) | 2022-04-27 | 2022-04-27 | A kind of synthetic method of 1-phenylpyrrolidine |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114656389B (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103172620A (en) * | 2009-06-11 | 2013-06-26 | 雅培制药有限公司 | Anti-viral compounds |
CN104884477A (en) * | 2012-12-27 | 2015-09-02 | 陶氏环球技术有限责任公司 | An enhylene based polymer |
WO2017088730A1 (en) * | 2015-11-23 | 2017-06-01 | 正大天晴药业集团股份有限公司 | Silicone-containing compound for resisting hepatitis c virus infection |
CN108350121A (en) * | 2015-09-30 | 2018-07-31 | 陶氏环球技术有限责任公司 | Major catalyst and use its polymerization |
-
2022
- 2022-04-27 CN CN202210448626.3A patent/CN114656389B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103172620A (en) * | 2009-06-11 | 2013-06-26 | 雅培制药有限公司 | Anti-viral compounds |
CN104884477A (en) * | 2012-12-27 | 2015-09-02 | 陶氏环球技术有限责任公司 | An enhylene based polymer |
CN108350121A (en) * | 2015-09-30 | 2018-07-31 | 陶氏环球技术有限责任公司 | Major catalyst and use its polymerization |
WO2017088730A1 (en) * | 2015-11-23 | 2017-06-01 | 正大天晴药业集团股份有限公司 | Silicone-containing compound for resisting hepatitis c virus infection |
Non-Patent Citations (5)
Title |
---|
Design, synthesis and identification of silicon-containing HCV NS5A inhibitors with pan-genotype activity;Baomin Liu,等;《European Journal of Medicinal Chem》;第148卷;95-105 * |
I2/NaH2PO2-mediated deoxyamination of cyclic ethers for the synthesis of N-aryl-substituted azacycles;Ying Lin,等;《New J. Chem.》;第45卷;21011-21014 * |
Nickel-Catalyzed Amination of Aryl Chlorides with Amides;Jinpeng Li,等;《Org. Lett.》;第23卷;687-691 * |
Reduced Phenalenyl in Catalytic Dehalogenative Deuteration and Hydrodehalogenation of Aryl Halides;Bhagat Singh,等;《J. Org. Chem.》;第86卷;7242-7255 * |
Seyyedeh Ameneh Alavi G.,等.NiFe2O4@SiO2@ZrO2/SO4 2 /Cu/Co nanoparticles: a novel, efficient, magnetically recyclable and bimetallic catalyst for Pd-free Suzuki, Heck and C–N cross-coupling reactions in aqueous media.《New J. Chem.》.2021,第45卷7741–7757. * |
Also Published As
Publication number | Publication date |
---|---|
CN114656389A (en) | 2022-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Hu et al. | A convenient synthesis of deuterium labeled amines and nitrogen heterocycles with KOt-Bu/DMSO-d6 | |
CN109053567B (en) | Method for reducing nitrogen-containing heterocyclic compound by hydrogen transfer | |
CN108314658B (en) | A kind of preparation method of multi-substituted oxazole derivatives | |
CN106749259A (en) | A kind of synthetic method of cyclopenta pyrimido azoles | |
CN104649857B (en) | Trifluoromethyl-substituted azide, amine and heterocycle compounds and preparing methods thereof | |
CN103012408B (en) | Synthesis method of epinastine | |
CN105153083B (en) | Preparation method for polysubstituted furan compound | |
CN114656389B (en) | A kind of synthetic method of 1-phenylpyrrolidine | |
WO2016197580A1 (en) | Method of synthesizing α-amino acid derivative with α-alkyl side chain substitution | |
CN110590854B (en) | Triazole carbene palladium metal complex and preparation method and application thereof | |
CN109912492B (en) | Synthetic method of 3-benzylidene isoindoline-1-one derivative | |
CN111978237A (en) | Preparation method of 3-morpholinyl-4-arylseleno maleimide compound | |
CN113636968B (en) | A kind of synthetic method of 3-acylpyrrole compound | |
CN117105845A (en) | An electrophilic trifluoromethylselenide reagent and its preparation method and application | |
CN106966948B (en) | A kind of synthetic method of gem-difluoro substituted pyrrolidone compound | |
CN106632440B (en) | A kind of preparation method of aryl-boric acid ester and ene boric acid ester | |
CN112778272B (en) | 2, 2' -biazaaryl ring bidentate ligand and preparation method and application thereof | |
CN112574225B (en) | Tetrahydrofuran dihydroquinoline compound and preparation method and application thereof | |
CN108484499B (en) | Process for preparing polysubstituted isoquinoline derivatives from hydroxylamine and alkynes | |
CN109020895A (en) | A kind of synthetic method of the 1- benzamido group substituted benzimidazole of metal catalytic | |
Meng et al. | Silver-Mediated Trifluoromethylthiolation-Cyclization-Hydrolysis: Access to F3CS-Containing Quinolinones | |
CN112125843A (en) | Preparation method of 3-hydroxymethyl-4-phenyl-3, 4-dihydroquinolinone compound | |
CN112279849A (en) | N-difluoromethyl azaindole compound and synthesis method thereof | |
CN115385909B (en) | Method for synthesizing imidazophenanthridine compounds through palladium-copper co-catalysis | |
CN114181182B (en) | Synthesis method of polysubstituted 4H-pyran compound |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |